Literature DB >> 26517103

The diagnostic criteria of pityriasis rosea and Gianotti-Crosti syndrome - a protocol to establish diagnostic criteria of skin diseases.

A Chuh1, V Zawar, G F Sciallis, A Lee.   

Abstract

We established and validated diagnostic criteria for pityriasis rosea and Gianotti-Crosti syndrome. In this paper, we compare and contrast both diagnostic criteria to formulate a protocol in establishing diagnostic criteria for other dermatological diseases. The diagnostic criteria are similar in employing clear dividing lines and conjunctions ('and/or') to assure high reliability. Both sets of criteria should be applicable for all ethnic groups. Spontaneous remission is not included, so diagnosis is not delayed while waiting for disease remission. Laboratory investigations are not enlisted, so that the criteria can be used in medical care systems in different parts of the world. The diagnostic criteria are different in that pathognomonic clinical manifestations exist for pityriasis rosea, such as the herald patch and the orientation of lesions along the lines of skin cleavages. These features, however, score low for sensitivity. These specific manifestations are not seen in Gianotti-Crosti syndrome. Such differences led to different categorisation of clinical features. Atypical variants are more common for pityriasis rosea. The diagnostic criteria for pityriasis rosea therefore do not include a list of differential diagnoses, while diagnostic criteria for Gianotti-Crosti syndrome do. Using this comparison, we constructed a protocol to establish diagnostic criteria for other skin diseases. We advocate the need to justify the establishment of diagnostic criteria, that multiple diagnostic criteria for the same disease should be avoided, that diagnostic criteria should be compatible with the disease classification if applicable, and that the scope should be well-delineated with regard to clinical variants. We outline the need for validation studies to assess the criteria-related validity, test-retest intra-clinician reliability, and inter-clinician reliability. We emphasise that the establishment of diagnostic criteria should not be a generic process. We also highlight limitations of diagnostic criteria, and emphasise that no diagnostic criteria can replace the bedside experience of clinicians.

Entities:  

Keywords:  acyclovir; azithromycin; hepatitis B virus; human herpesvirus 7; paraviral exanthems; viral exanthems

Mesh:

Year:  2015        PMID: 26517103     DOI: 10.4997/JRCPE.2015.310

Source DB:  PubMed          Journal:  J R Coll Physicians Edinb        ISSN: 1478-2715


  4 in total

Review 1.  Pityriasis Rosea, Gianotti-Crosti Syndrome, Asymmetric Periflexural Exanthem, Papular-Purpuric Gloves and Socks Syndrome, Eruptive Pseudoangiomatosis, and Eruptive Hypomelanosis: Do Their Epidemiological Data Substantiate Infectious Etiologies?

Authors:  Antonio Chuh; Vijay Zawar; Gabriel F Sciallis; Werner Kempf; Albert Lee
Journal:  Infect Dis Rep       Date:  2016-03-21

2.  The Serum Immunoglobulin E Level: Is There a Relationship With the Clinical Course of the Gianotti-Crosti Syndrome?

Authors:  Andrea Bassi; Fausto Pedaci; Teresa Oranges; Chiara Azzari; Luisa Galli; Silvia Ricci; Cesare Filippeschi; Elisabetta Venturini
Journal:  Front Pediatr       Date:  2021-02-25       Impact factor: 3.418

3.  Occult Hepatitis B Virus Infections (Often with Human Herpesvirus 7 Co-Infection) Detected in Pityriasis rosea Patients: A Pilot Study.

Authors:  Abhishek De; Subrata Roy; Soumi Sukla; Asad Ansari; Subhajit Biswas
Journal:  Indian J Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.494

4.  A Gianotti-Crosti-like eruption in the setting of SARS-CoV-2 infection.

Authors:  Emilio de Dios Berná-Rico; Claudia Álvarez-Pinheiro; Patricia Burgos-Blasco; Gerald Selda-Enríquez; Carlos Azcárraga-Llobet; Montserrat Fernández-Guarino; Diego Fernández-Nieto
Journal:  Dermatol Ther       Date:  2021-08-04       Impact factor: 3.858

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.